✦ LIBER ✦

A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer

✍ Scribed by Martin Schuler, Ahmad Awada, Philipp Harter, Jean Luc Canon, Kurt Possinger, Marcus Schmidt, Jacques De Grève, Patrick Neven, Luc Dirix, Walter Jonat, Matthias W. Beckmann, Jochen Schütte, Peter A. Fasching, Nina Gottschalk, Tatiana Besse-Hammer, et al

Book ID: 118796650
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 303 KB
Volume: 134
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-012-2126-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of trastuzumab plus

Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer

✍ Tomo Osako; Yoshinori Ito; Shunji Takahashi; Nahomi Tokudome; Takuji Iwase; Kiyo 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 293 KB

A multicentre phase II study to evaluate

A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer

✍ Juan Bayo; María Lomas; Javier Salvador; Alberto Moreno; Manuel Ruiz; Alberto Ro 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 332 KB

Efficacy and safety of three-weekly herc

Efficacy and safety of three-weekly herceptin with paclitaxel in women with her2-positive metastatic breast cancer: preliminary results of a phase II trial

✍ S. Verma; B. Leyland-Jones; J.-P. Ayoub; K. Gelmon; A. Arnold; C. Szakacs; J. Ho 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

5020 Pharmacokinetics (PK), safety, and

5020 Pharmacokinetics (PK), safety, and efficacy of trastuzumab (T)-DM1, a HER2 antibody-drug conjugate (ADC), in patients with HER2+ metastatic breast cancer (MBC): phase I and phase II trial results

✍ H. Burris III; S. Vukelja; I. Krop; S. Modi; B. Klencke; S. Girish; M.X. Sliwkow 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

A phase II multicenter trial of weekly h

A phase II multicenter trial of weekly herceptin with navelbine in chemonaive patients with her2 positive metastatic breast cancer

✍ M. Jahanzeb; J. Mortimer; F. Yunus; D. Irwin; J. Speyer; A. Koletsky; P. Klein; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Metronomic oral combination chemotherapy

Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer

✍ Masataka Yoshimoto, Shintaro Takao, Masaru Hirata… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 245 KB